Kura Oncology, Inc. (KURA)

NASDAQ: KURA · Real-Time Price · USD

9.01

-0.30 (-3.22%)

At close: Jul 31, 2026, 4:00 PM EDT

9.17

+0.16 (1.78%)

After-hours: Jul 31, 2026, 7:34 PM EDT

Kura Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	800	913	681	1,069	848	932
Market Cap Growth	46.66%	33.97%	-36.27%	26.11%	-9.04%	-56.89%
Enterprise Value	243.31	266.03	-29.43	662.4	423.82	420.92
Last Close Price	9.01	10.39	8.71	14.38	12.41	14.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	11.17	13.53	12.65	-	-	-
PB Ratio	7.41	5.24	1.65	2.69	2.02	1.84
P/TBV Ratio	7.35	5.23	1.81	2.65	1.98	1.83
P/FCF Ratio	-	-	5.09	-	-	-
P/OCF Ratio	-	-	5.07	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.40	3.94	-0.55	-	-	-
EV/EBITDA Ratio	-	-	0.15	-	-	-
EV/EBIT Ratio	-	-	0.15	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.21	0.11	0.03	0.04	0.03	0.01
Debt / FCF Ratio	-	-	0.12	-	-	-
Net Debt / Equity Ratio	-5.16	-3.71	-1.72	-1.02	-1.01	-1.01
Net Debt / EBITDA Ratio	1.72	2.14	3.70	2.47	3.05	3.91
Net Debt / FCF Ratio	6.59	9.15	-5.31	3.25	3.83	4.84
Asset Turnover	0.09	0.09	0.09	0	0	0
Inventory Turnover	-	0.28	-	-	-	-
Quick Ratio	5.81	5.78	9.27	12.02	18.21	23.07
Current Ratio	6.15	6.06	9.46	12.26	18.56	23.26
Return on Equity (ROE)	-208.90%	-94.82%	-42.91%	-37.34%	-29.31%	-23.35%
Return on Assets (ROA)	-46.79%	-40.57%	-32.33%	-36.63%	-28.25%	-22.22%
Return on Capital Employed (ROCE)	-55.50%	-46.61%	-35.28%	-39.20%	-29.64%	-23.17%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
FCF Yield	-	-	19.64%	-	-	-
Buyback Yield / Dilution	-1.08%	-1.76%	-17.66%	-9.31%	-0.96%	-25.01%
Total Shareholder Return	-1.08%	-1.76%	-17.66%	-9.31%	-0.96%	-25.01%

SEC Filings: 10-K · 10-Q